Comparison

VX702 European Partner

Manufacturer TargetMol
Category
Type Molecules
Specific against other
Amount 100mg
Item no. TMO-T2513-100mg
CASRN 745833-23-2
eClass 6.1 32169090
eClass 9.0 32169090
Available
Description
VX-702 is a highly selective inhibitor of p38alpha MAPK, 14-fold higher potency against the p38alpha versus p38beta. Phase 2.
Formulate
C19H12F4N4O2
Shipping temperature
Cool Pack
Smeles
NC(=O)N(C1=NC(=C(C=C1)C(N)=O)C1=C(F)C=C( F)C=C1)C1=C(F)C=CC=C1F
Storage Temperature
-20C
Target's name
p38 MAPK inhibitor

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100mg
Available: In stock
available

Delivery expected until 5/23/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close